234 related articles for article (PubMed ID: 23643298)
1. Surgery for metastatic neuroendocrine tumors with occult primaries.
Bartlett EK; Roses RE; Gupta M; Shah PK; Shah KK; Zaheer S; Wachtel H; Kelz RR; Karakousis GC; Fraker DL
J Surg Res; 2013 Sep; 184(1):221-7. PubMed ID: 23643298
[TBL] [Abstract][Full Text] [Related]
2. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
3. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
4. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience.
Gillams A; Cassoni A; Conway G; Lees W
Abdom Imaging; 2005; 30(4):435-41. PubMed ID: 15759207
[TBL] [Abstract][Full Text] [Related]
5. [Liver transplantation in metastatic neuroendocrine tumors. Symptom-free intervals and cure possible].
Ahlman H; Olausson M; Friman S; Herlenius G; Cahlin C; Nilsson O; Jansson S; Wängberg B
Lakartidningen; 2007 Sep 5-11; 104(36):2519-23. PubMed ID: 17939441
[No Abstract] [Full Text] [Related]
6. The palliative benefit of aggressive surgical intervention for both hepatic and mesenteric metastases from neuroendocrine tumors.
Chambers AJ; Pasieka JL; Dixon E; Rorstad O
Surgery; 2008 Oct; 144(4):645-51; discussion 651-3. PubMed ID: 18847650
[TBL] [Abstract][Full Text] [Related]
7. Identification of unknown primary tumors in patients with neuroendocrine liver metastases.
Wang SC; Parekh JR; Zuraek MB; Venook AP; Bergsland EK; Warren RS; Nakakura EK
Arch Surg; 2010 Mar; 145(3):276-80. PubMed ID: 20231629
[TBL] [Abstract][Full Text] [Related]
8. A single institution's experience with surgical cytoreduction of stage IV, well-differentiated, small bowel neuroendocrine tumors.
Boudreaux JP; Wang YZ; Diebold AE; Frey DJ; Anthony L; Uhlhorn AP; Ryan P; Woltering EA
J Am Coll Surg; 2014 Apr; 218(4):837-44. PubMed ID: 24655881
[TBL] [Abstract][Full Text] [Related]
9. Surgery on neuroendocrine tumours.
Akerström G; Hellman P
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):87-109. PubMed ID: 17382267
[TBL] [Abstract][Full Text] [Related]
10. [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract].
Zimmer T; Faiss S; Buhr HJ; Hamm B; Wiedenmann B
Bildgebung; 1995 Mar; 62(1):5-13. PubMed ID: 7756824
[TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumors of the pancreas].
Gorgone A; Calbo L; Melita G; Riso F; Tigano D; Barbuscia M
Chir Ital; 1999; 51(4):309-12. PubMed ID: 10633841
[TBL] [Abstract][Full Text] [Related]
12. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
[TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
[TBL] [Abstract][Full Text] [Related]
14. Impact of lymphadenectomy on survival after surgery for sporadic gastrinoma.
Bartsch DK; Waldmann J; Fendrich V; Boninsegna L; Lopez CL; Partelli S; Falconi M
Br J Surg; 2012 Sep; 99(9):1234-40. PubMed ID: 22864882
[TBL] [Abstract][Full Text] [Related]
15. Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors.
Keck KJ; Maxwell JE; Menda Y; Bellizzi A; Dillon J; O'Dorisio TM; Howe JR
Surgery; 2017 Jan; 161(1):272-279. PubMed ID: 27863780
[TBL] [Abstract][Full Text] [Related]
16. Metastatic nonfunctioning pancreatic neuroendocrine carcinoma to liver: surgical treatment and outcomes.
Cusati D; Zhang L; Harmsen WS; Hu A; Farnell MB; Nagorney DM; Donohue JH; Que FG; Reid-Lombardo KM; Kendrick ML
J Am Coll Surg; 2012 Jul; 215(1):117-24; discussion 124-5. PubMed ID: 22726741
[TBL] [Abstract][Full Text] [Related]
17. Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung).
Kim SJ; Kim JW; Oh DY; Han SW; Lee SH; Kim DW; Im SA; Kim TY; Heo DS; Bang YJ
Am J Clin Oncol; 2012 Dec; 35(6):549-56. PubMed ID: 21659833
[TBL] [Abstract][Full Text] [Related]
18. Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors.
Osborne DA; Zervos EE; Strosberg J; Boe BA; Malafa M; Rosemurgy AS; Yeatman TJ; Carey L; Duhaine L; Kvols LK
Ann Surg Oncol; 2006 Apr; 13(4):572-81. PubMed ID: 16511671
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of neuroendocrine tumors (including carcinoid).
Doherty G
Curr Opin Endocrinol Diabetes Obes; 2013 Feb; 20(1):32-6. PubMed ID: 23183358
[TBL] [Abstract][Full Text] [Related]
20. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.
Hellman P; Lundström T; Ohrvall U; Eriksson B; Skogseid B; Oberg K; Tiensuu Janson E; Akerström G
World J Surg; 2002 Aug; 26(8):991-7. PubMed ID: 12016480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
